Violich Capital Management Inc. Takes $499,000 Position in Astera Labs, Inc. $ALAB

Violich Capital Management Inc. acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 3,000 shares of the company’s stock, valued at approximately $499,000.

Other large investors also recently modified their holdings of the company. Nordea Investment Management AB bought a new stake in shares of Astera Labs in the 4th quarter valued at approximately $2,028,000. Geneva Partners LLC bought a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $1,876,000. Numerai GP LLC grew its stake in shares of Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares during the period. Handelsbanken Fonder AB grew its stake in shares of Astera Labs by 289.5% in the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after purchasing an additional 93,800 shares during the period. Finally, Paragon Advisors LLC bought a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $1,829,000. 60.47% of the stock is currently owned by institutional investors.

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 94,971 shares of the company’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. This represents a 5.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer directly owned 192,083 shares in the company, valued at approximately $23,781,796.23. This represents a 5.88% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 1,064,888 shares of company stock worth $150,764,723. 12.50% of the stock is owned by company insiders.

Astera Labs Price Performance

NASDAQ ALAB opened at $195.65 on Friday. The firm has a market cap of $33.51 billion, a PE ratio of 132.20, a price-to-earnings-growth ratio of 4.21 and a beta of 3.35. Astera Labs, Inc. has a one year low of $69.26 and a one year high of $262.90. The stock’s 50 day simple moving average is $143.77 and its 200 day simple moving average is $153.99.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 19.36% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period in the prior year, the company earned $0.33 EPS. Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts expect that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on ALAB shares. UBS Group initiated coverage on Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Morgan Stanley increased their price target on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday. Barclays increased their price target on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday. Royal Bank Of Canada increased their price target on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, TD Cowen increased their price target on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday. Fifteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $229.65.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.